Andrew Fisher, General Counsel at Verona Pharma plc (VRNA), sold 19,168 shares at $13.14 ($252K) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Open-market sale of $252k VRNA by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.14 | 9,584 | $126K | 50.0% |
| 2 | $13.14 | 9,584 | $126K | 50.0% |
| Total | $13.14 avg | 19,168 | $252K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-01 | $468K | — | Filing → |